Nakamoto Inc.

NASDAQ:NAKA

Financial - Capital Markets

Financial Services
$4.45 +0.03%

+$0.00 today

Market cap
$77.44M
Beta
-0.90
P/E (TTM)
-0.2
EPS (TTM)
-$18.22
52W Low $4.05High $679.20

Volume 0.13M

Average 0.24M

NAKA Gross Profit

Revenue minus cost of revenue: what remains to cover operating expenses after paying for what was sold.

Nakamoto Inc.NASDAQ: NAKA

Gross Profit · Q1 FY2026 · quarter ended Mar 2026

Gross profit remains negative

Q1 FY2026 gross profit was -$4.9M, compared with -$431K a year earlier. Trailing-twelve-month gross profit was -$14.74M.

Context

  • Gross profit amounted to 508.8% of revenue in FY2025, up 477.8 pp from a year earlier.
  • Gross profit increased in 0 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly gross profit holds near -$4.9M or moves back toward the trailing-twelve-month quarterly average of -$3.68M.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$4.9M+53.9% QoQ
Last fiscal yearDec 2025
-$9.27M-999.8% YoY
LTMMar 2026
-$14.74M-798.8% YoY
Gross Profit past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-1037.1%——
1 year-999.8%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Gross Profit history

USD · from the income statement

Latest · FY2025
(9.27M) USD
Year-over-year change
-999.8%

Gross Profit vs competitors

How NAKA compares with its peers on the latest reported figures

  • NAKA's LTM Mar 2026 gross profit of -$14.74M is the 9th highest of the 11 companies compared; the peer median is $52.26M.
  • Its year-over-year change of -798.8% is the 9th highest of 10, against a peer median of +14.9%.
  • Gross profit amounts to 376.0% of revenue for NAKA, versus a peer median of 69.9%.
NAKA Competitors Peer median
Gross Profit for NAKA and competitors
Company Period LTM YoY 3-year CAGR% of revenue
DHDefinitive Healthcare Corp.LTM Mar 2026$172.84M -9.4%+0.6%72.5%
AMRNAmarin Corporation plcLTM Mar 2026$112.77M +52.6%-20.7%52.5%
DCTHDelcath Systems, Inc.LTM Mar 2026$77.75M +70.1%+230.6%86.0%
CLLSCellectis S.A.LTM Mar 2026$55.76M +43.8%+80.8%81.9%
SOPHSOPHiA GENETICS S.A.LTM Mar 2026$54.62M +19.4%+15.2%67.3%
SLPSimulations Plus, Inc.LTM Feb 2026$49.91M +14.9%+2.4%62.0%
LRMRLarimar Therapeutics, Inc.LTM Mar 2026$0 ———
LYELLyell Immunopharma, Inc.LTM Mar 2026-$2.3M -3640.0%—7422.6%
NAKANakamoto Inc.LTM Mar 2026-$14.74M -798.8%—376.0%
DBVTDBV Technologies S.A.LTM Mar 2026-$17.4M -146.9%——
AGLAgilon Health, Inc.LTM Mar 2026-$159.48M -716.8%—2.7%
Peer median (excluding NAKA) $52.26M+14.9%+8.8%69.9%

Competitors are the stored peer set for NAKA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue2.5M3.79M3.77M2.72M1.82M
Cost of Revenue1.59M152.39K226.17K3.56M11.09M
Gross Profit914.92K3.63M3.54M(842.57K)(9.27M)
Gross Margin36.5%96.0%94.0%-31.0%-508.8%
Research & Development002.5K377.73K0
Selling, General & Admin853.58K6.27M5.05M1.91M11.76M
Operating Expenses853.58K6.33M5.16M2.5M187.87M
Depreciation & Amortization63.4K122.01K203.22K220.33K241.99K
EBITDA124.74K(2.42M)(1.36M)(3M)(44.93M)
EBITDA Margin5.0%-63.9%-36.0%-110.4%-2466.7%
Operating Income61.34K(2.69M)(1.62M)(3.35M)(197.14M)
Operating Margin2.4%-71.1%-43.0%-123.1%-10824.0%
Interest Income00000
Interest Expense0055.84K393.45K7.06M
Other Income / Expenses88K152.82K2.76K(270.88K)144.91M
Income Before Tax149.34K(2.54M)(1.62M)(3.62M)(52.23M)
Pre-Tax Margin6.0%-67.1%-42.9%-133.0%-2867.6%
Income Tax Expense00000
Net Income149.34K(2.54M)(1.62M)(3.62M)(52.23M)
Net Margin6.0%-67.1%-42.9%-133.0%-2867.6%
EPS (Basic)0.03(0.43)(0.27)(0.67)(10.40)
EPS (Diluted)0.03(0.43)(0.27)(0.67)(10.40)
Weighted Avg Shares5.97M5.89M5.89M5.39M11.36M
Weighted Avg Shares (Diluted)5.97M5.89M5.89M5.39M11.36M

Nakamoto Inc.

NASDAQ:NAKA

Intrinsic Alpha fair value

Locked

Current Price

$4.45

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.